USA - NASDAQ:COCH - US29415V1098 - Common Stock
The current stock price of COCH is 0.7382 USD. In the past month the price decreased by -1.11%. In the past year, price decreased by -68.43%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 24.81 | 215.43B | ||
| ISRG | INTUITIVE SURGICAL INC | 62.99 | 194.43B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.55 | 146.66B | ||
| SYK | STRYKER CORP | 27.16 | 136.74B | ||
| MDT | MEDTRONIC PLC | 16.23 | 115.10B | ||
| BDX | BECTON DICKINSON AND CO | 12.4 | 50.70B | ||
| IDXX | IDEXX LABORATORIES INC | 59.67 | 57.33B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.59 | 49.17B | ||
| RMD | RESMED INC | 25.02 | 36.15B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.09 | 33.72B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.61 | 26.55B | ||
| STE | STERIS PLC | 24.82 | 23.32B |
Envoy Medical, Inc. is a hearing health company, which engages in providing medical technologies across the hearing loss spectrum. The company is headquartered in White Bear Lake, Minnesota and currently employs 42 full-time employees. The company went IPO on 2021-03-02. The firm is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.
ENVOY MEDICAL INC
4875 White Bear Parkway
White Bear Lake MINNESOTA US
Employees: 42
Phone: 16513618000
Envoy Medical, Inc. is a hearing health company, which engages in providing medical technologies across the hearing loss spectrum. The company is headquartered in White Bear Lake, Minnesota and currently employs 42 full-time employees. The company went IPO on 2021-03-02. The firm is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.
The current stock price of COCH is 0.7382 USD. The price decreased by -8.3% in the last trading session.
COCH does not pay a dividend.
COCH has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
9 analysts have analysed COCH and the average price target is 7.99 USD. This implies a price increase of 982.36% is expected in the next year compared to the current price of 0.7382.
ENVOY MEDICAL INC (COCH) has a market capitalization of 21.17M USD. This makes COCH a Nano Cap stock.
The outstanding short interest for ENVOY MEDICAL INC (COCH) is 5.24% of its float.
Over the last trailing twelve months COCH reported a non-GAAP Earnings per Share(EPS) of -1.44. The EPS decreased by -90.24% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -284.89% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
9 analysts have analysed COCH and the average price target is 7.99 USD. This implies a price increase of 982.36% is expected in the next year compared to the current price of 0.7382.
For the next year, analysts expect an EPS growth of 13.56% and a revenue growth -17.84% for COCH